Simplex Trading
ANIX icon

Simplex Trading’s Anixa Biosciences ANIX Stock Holding History

Simplex Trading’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,965
Closed -$14.7K – 8984
2025
Q4 		$15.5K Sell
4,965
-3,219
-39% -$13.2K ﹤0.01% 6691
2025
Q3 		$27K Buy
+8,184
New +$25.9K ﹤0.01% 7052
2024
Q4 		– Sell
-8,571
Closed -$26.6K – 8429
2024
Q3 		$26K Buy
8,571
+4,345
+103% +$13.4K ﹤0.01% 6455
2024
Q2 		$9K Sell
4,226
-4,825
-53% -$13.7K ﹤0.01% 7474
2024
Q1 		$28K Buy
9,051
+8,758
+2,989% +$34.9K ﹤0.01% 6797
2023
Q4 		$1K Sell
293
-721
-71% -$2.43K ﹤0.01% 8425
2023
Q3 		$3K Buy
+1,014
New +$3.55K ﹤0.01% 7849
2023
Q2 		– Sell
-16,962
Closed -$65.3K – 8889
2023
Q1 		$72K Buy
16,962
+468
+3% +$2.05K ﹤0.01% 5509
2022
Q4 		$70K Buy
16,494
+4,196
+34% +$20.2K ﹤0.01% 5464
2022
Q3 		$60K Buy
12,298
+9,686
+371% +$39.3K ﹤0.01% 6181
2022
Q2 		$7K Sell
2,612
-13,461
-84% -$42.4K ﹤0.01% 8545
2022
Q1 		$44K Buy
+16,073
New +$47.1K ﹤0.01% 7297

Other funds holding ANIX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading's ANIX Position: Q1 2026 in Review

Simplex Trading sold out of Anixa Biosciences (ANIX) in Q1 2026, closing a stake of 4,965 shares — an estimated $14.7K sold.

Simplex Trading first reported a position in ANIX in Q1 2022 and held it in 12 quarters. The position peaked at $72K in Q1 2023. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Simplex Trading reported no remaining Anixa Biosciences position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 4,965 Anixa Biosciences shares in Q1 2026, an estimated $14.7K.
  • Simplex Trading first reported a position in Anixa Biosciences in Q1 2022 and held it in 12 quarters.
  • Simplex Trading's Anixa Biosciences position peaked at $72K in Q1 2023.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.